Baker McKenzie offers multi-disciplinary advice to local and international life sciences clients, providing comprehensive coverage of regulatory, consumer safety, competition, IP, data protection, compliance and contractual matters. Clients turn to the team for support on licence requirements for product manufacturing, sales, distribution and advertising under local law, as well as advice related to the acquisition of product approvals, data exclusivity issues, pricing, delisting, adverse event reporting, and product liability and recall matters. Antitrust and competition law in the life sciences and medical devices industries is another focus area, with the firm also sought out for support on healthcare-related trademark enforcement and trademark and patent prosecution work. The team is also active in healthcare M&A, frequently representing multinational clients. Commercial and contractual matters and liability disputes (including product safety and regulatory non-compliance issues) are also handled. Practice head Vanina Caniza is a life sciences specialist and first port of call for multinational life sciences groups seeking support on corporate compliance, commercial agreements, M&A and regulatory advice. Caniza also serves as the global chair of the firm’s healthcare and life sciences industry group, and has developed deep technical knowledge after completing post-graduate studies in biotechnology. Senior associate Rocío Rojas Iglesias focuses on regulatory and commercial law matters, with the practice also able to draw on the experience of litigation and arbitration lawyer Santiago Maqueda when required.

Marval O’Farrell Mairal‘s highly specialised, standalone life sciences practice is the first port of call for premier international and local clients, and leverages the firm’s full-service capabilities to provide comprehensive, multi-disciplinary advice that covers large, complex cross-border life sciences and healthcare transactions, antitrust issues, regulatory matters, product registrations, compliance, and patent prosecution and enforcement. The firm is frequently called on to assist multinational life sciences and healthcare businesses with setting up operations in Argentina, and will also lead and coordinate pan-regional deals in the sector. Practice head Martín Mosteirin is an industry reference and advises major life sciences clients on a wide range of regulatory, transactional and contentious matters. A talented bench of senior associates, including Camila Leone (who has a focus on M&A, healthcare claims, and restructurings) and Carolina Andrea Ramírez (who routinely advises on regulatory strategy and compliance) provide capable support.

Allende & Brea‘s fast-growing life sciences practice assists life sciences and healthcare clients with a comprehensive service that covers corporate, contractual, transactional, regulatory, IP, data protection, compliance, antitrust, labour, tax, customs, and foreign exchange matters. The firm has picked up an increasing volume of transactional work and is well versed in regulatory matters, including work involving the National Administration of Drugs, Food and Medical Technology (ANMAT) and the National and Provincial Ministries of Health. Other areas of expertise include clinical trials, the import, export and sales of medical products in Argentina, healthcare packaging and labelling, and compliance advice and training. The firm has also built up niche expertise in medicinal cannabis and hemp regulatory matters. The practice is co-led by administrative law and regulatory specialist María Morena Del Río and the highly rated Fernando Martínez Zuviría, who covers regulatory, licensing, transactional and distribution matters, as well as playing a leading role in advising on new medical cannabis and hemp regulations in Argentina. At associate level, seniors Vanesa Fernández (an expert in life sciences regulation) and Lucrecia Re (who focuses on administrative law and regulation) are the main points of contact.

Beccar Varela‘s well-established life sciences practice provides pharmaceutical, medical devices, cosmetics, healthcare services and digital health companies with a full-service offering that includes coverage of commercial matters, IP, litigation, licensing and M&A in the industry. The firm is particularly well known for its deep regulatory expertise, and is called on for support with clinical trials, drug approvals, and issues related to post-trial access to study drugs. Other active areas include work involving orphan drugs, Argentina’s exceptional access regime for pharmaceuticals, and medicinal cannabis. Practice head Ana Andrés is well regarded and recognised for her deep knowledge of healthcare regulation. Senior associate Malvina Acuña focuses on healthcare and life sciences and handles a mix of transactional, corporate and company law work.

Clients turn to Bomchil for advice on clinical trials, telemedicine, healthcare regulation and tobacco-free products, as well clinical practice guidelines in the field of obstetrics and surrogate motherhood, and liability management. The team is particularly well known for handling complex medical malpractice cases and providing pre-trial counsel to mitigate claims risk. The practice is led by Melisa Romero, who has extensive experience of handling medical malpractice proceedings and also advises clients on claims and cases related to adverse effects arising from Covid-19 vaccines and clinical trials. Senior associate María Victoria Casale has played a key role in managing obstetrics and neonatology malpractice cases.

Bruchou & Funes de Rioja advises clients in the pharmaceutical, health, personal hygiene, cosmetics, biotechnology and medical device industries, and covers commercial agreements, strategic partnerships, litigation and M&A, as well as trade mark, patent and other IP matters. The practice is co-led by respected corporate and M&A partner Estanislao Olmos, who focuses on M&A and commercial agreements in the sector, and IP lawyer Dámaso Pardo, who has extensive experience in filing and prosecuting patent applications for pharmaceutical, medical device and biotechnology companies. Administrative law and regulatory expert Juan Zocca works on regulatory matters related to medicinal cannabis, drugs, healthcare and health technologies, and regularly supports clients in the registration of products and companies before ANMAT, and with the application of the chemical precursors regime to pharmaceutical companies.